ClinicalTrials.Veeva

Menu

Clinical and Radiographic Evaluation in Pulpotomy of Primary Molars Using Protooth Vs. MTA

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Clinical Evaluation Including Pain and Swelling

Treatments

Drug: Novel fast-setting calcium silicate cement (Protooth)

Study type

Interventional

Funder types

Other

Identifiers

NCT04710160
Pedo193

Details and patient eligibility

About

The aim of the study is to evaluate the clinical and radiographic success in pulpotomy using novel fast-setting calcium silicate cement (Protooth) versus MTA in exposed primary molars.

Enrollment

40 estimated patients

Sex

All

Ages

4 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Complete physical and mental health, with no confounding history of systemic disease and/or use of special local or systemic drugs

  • No allergic reactions recorded in patient history

  • Having primary molar teeth in one jaw, having deep caries and vital pulp.

  • No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of vestibule

  • Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test

    • Radiographic criteria:
  • No sign of radiolucency in periapical or furcation area

  • No widening of PDL space or loss of lamina dura continuity

  • No evidence of internal/external pathologic root resorption

Exclusion criteria

  • Lack of informed consent by the child patient's parent
  • Lack of informed consent by the child patient's parent
  • Unable to attend follow-up visits.
  • Refusal of participation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Novel fast setting calcium silicate ( Protooth)
Active Comparator group
Description:
In the form of powder and liquid to be mixed together to form paste.
Treatment:
Drug: Novel fast-setting calcium silicate cement (Protooth)
MTA
Experimental group
Description:
In form of powder to be mixed with saline to form paste.
Treatment:
Drug: Novel fast-setting calcium silicate cement (Protooth)

Trial contacts and locations

1

Loading...

Central trial contact

Passant Nagy, Doctorat; Adel Elbardissy, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems